Having a sophisticated understanding of both medicine and biomedical engineering gives graduates the tools they will need to develop new treatments using nanomedicine, neuroengineering, tissue engineering and imaging techniques, Dr. Wodicka said.
About 10 students now are pursuing biomedical engineering doctoral degrees at Purdue through the program. The program's goal is to enroll three new engineering students each year and have 21 such students enrolled at any given time.
Started in the 1960s, the M.D./Ph.D. program was transformed in 2002 with the addition of funding from the Indiana Genomics Initiative, the $155 million initiative funded by grants from the Lilly Endowment. Support from INGEN, along with additional support from the School of Medicine, individual graduate programs and private philanthropy, substantially increased the level of scholarship support for the program, resulting in a tripling of applications.
With the appointment of Dr. Clapp and Maureen Harrington, Ph.D. professor of biochemistry and molecular biology, as directors, the program's educational curriculum has been revamped, the collaboration between IU and Purdue strengthened and new opportunities for research, mentoring and interactions with leading physician scientists from across the country have been added. The program has boosted efforts to recruit top applicants, resulting in more applicants from across the country. Seventeen percent of those enrolled since 2002 have been minority students.
'/>"/>
| Contact: Eric Schoch eschoch@iupui.edu 317-274-7722 Indiana University Source:Eurekalert |